| Earnings Per Share [Text Block] |
Note 14. Net Income (Loss) Per Share
The computation of basic and diluted net income (loss) per share attributable to common stockholders for the three and nine months ended September 30, 2026 and 2025 was as follows:
| | | Three Months Ended September 30, | | | Nine Months Ended September 30, | |
| (in thousands, except share and per share data) | | 2026 | | | 2025 | | | 2026 | | | 2025 | |
| Numerator: | | | | | | | | | | | | | | | | |
| Net income (loss) attributable to common stockholders | | $ | 3,915 | | | $ | (8,777 | ) | | $ | (17,600 | ) | | $ | (16,947 | ) |
| Less change in fair value of dilutive common stock warrant liabilities, net of tax | | | (200 | ) | | | — | | | | — | | | | — | |
| Plus interest expense on dilutive convertible notes payable, net of tax | | | 367 | | | | — | | | | — | | | | — | |
| Less change in fair value of derivative liabilities attributable to dilutive convertible notes payable, net of tax | | | (3,368 | ) | | | — | | | | — | | | | — | |
| Net income (loss) attributable to common stockholders – Diluted | | $ | 714 | | | $ | (8,777 | ) | | $ | (17,600 | ) | | $ | (16,947 | ) |
| | | | | | | | | | | | | | | | | |
| Denominator: | | | | | | | | | | | | | | | | |
| Weighted average common shares outstanding | | | 13,079,599 | | | | 10,284,674 | | | | 12,374,096 | | | | 9,549,661 | |
| Weighted average effect of dilutive securities: | | | | | | | | | | | | | | | | |
| Stock options | | | 47,802 | | | | — | | | | — | | | | — | |
| Common stock warrants | | | 6,127 | | | | — | | | | — | | | | — | |
| Convertible notes payable | | | 1,535,214 | | | | — | | | | — | | | | — | |
| Weighted average common shares outstanding – Diluted | | | 14,668,742 | | | | 10,284,674 | | | | 12,374,096 | | | | 9,549,661 | |
| | | | | | | | | | | | | | | | | |
| Net income (loss) per share attributable to common stockholders – basic and diluted | | | | | | | | | | | | | | | | |
| Basic | | $ | 0.30 | | | $ | (0.85 | ) | | $ | (1.42 | ) | | $ | (1.77 | ) |
| Diluted | | $ | 0.05 | | | $ | (0.85 | ) | | $ | (1.42 | ) | | $ | (1.77 | ) |
The following shares of potentially dilutive securities were excluded from the computation of diluted net income (loss) per share attributable to common stockholders for the three and nine months ended September 30, 2026 and 2025 because they were antidilutive, out-of-the-money, or the issuance of such shares is contingent upon certain conditions that were not satisfied by the end of the period:
| | | Three Months Ended September 30, | | | Nine Months Ended September 30, | |
| | | 2026 | | | 2025 | | | 2026 | | | 2025 | |
| Convertible notes payable (see Note 8) | | | 62,500 | | | | 1,457,849 | | | | 1,503,596 | | | | 1,457,849 | |
| Common stock warrants (see Note 13) | | | 7,760,247 | | | | 6,818,518 | | | | 7,910,247 | | | | 6,818,518 | |
| Options to purchase common stock (see Note 11) | | | 3,278,643 | | | | 2,681,534 | | | | 3,474,139 | | | | 2,681,534 | |
| Unvested restricted stock awards (see Note 11) | | | — | | | | 36,778 | | | | — | | | | 36,778 | |
| Contingent earn-out shares (see Note 2) | | | — | | | | 329,628 | | | | — | | | | 329,628 | |
| Total shares excluded from diluted net income (loss) per share | | | 11,101,390 | | | | 11,324,307 | | | | 12,887,982 | | | | 11,324,307 | |
|